Skip to content

VFMF · BATS · ETF

Vanguard U.S. Multifactor ETF (VFMF) Price, Holdings & Fees

$214.06+0.92%+$1.96End-of-day price as of Oct 9, 2026

Vanguard U.S. Multifactor ETF (VFMF) closed at $214.06 on Oct 9, 2026, up 0.92% from the previous close of $212.10.

Share price, past year

1Y +16.99%

52-week range $176.14 – $224.56. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$214.06
Sep 30, 2026$220.70
Aug 31, 2026$220.26
Jul 31, 2026$207.28
Jun 30, 2026$213.07
May 29, 2026$216.05
Apr 30, 2026$201.20
Mar 31, 2026$199.09
Feb 27, 2026$193.23
Jan 30, 2026$193.72
Dec 31, 2025$188.17
Nov 28, 2025$180.74
Oct 31, 2025$180.83

Key statistics

Expense ratio
0.18%
as of Nov 30, 2025
Net assets
$641.9M
as of May 31, 2026
Holdings
617
as of May 31, 2026
52-week range
$176.14 – $224.56

Vanguard U.S. Multifactor ETF's expense ratio is 0.18%: $18.00 a year on $10,000 invested.

Holdings

Vanguard U.S. Multifactor ETF held 617 investments worth $641.90M as of May 31, 2026. Its largest holding was Micron Technology Inc, at 1.25% of the fund.

Vanguard U.S. Multifactor ETF largest holdings by share of net assets
#Holding% of fundValue
1Micron Technology Inc1.25%$8.00M
2Newmont Corp0.89%$5.70M
3Bristol-Myers Squibb Co0.88%$5.63M
4ConocoPhillips0.86%$5.55M
5Bank of New York Mellon Corp/The0.86%$5.53M
6EOG Resources Inc0.84%$5.38M
7Travelers Cos Inc/The0.83%$5.33M
8Altria Group Inc0.83%$5.32M
9Cisco Systems Inc0.83%$5.32M
10Merck & Co Inc0.81%$5.18M
11Alphabet Inc0.79%$5.06M
12Regeneron Pharmaceuticals Inc0.77%$4.96M
13Amgen Inc0.75%$4.79M
14AbbVie Inc0.74%$4.74M
15Gilead Sciences Inc0.73%$4.71M
16FedEx Corp0.72%$4.64M
17CVS Health Corp0.72%$4.62M
18Dell Technologies Inc0.71%$4.54M
19HCA Healthcare Inc0.68%$4.36M
20Allstate Corp/The0.67%$4.31M
21Western Digital Corp0.66%$4.25M
22McKesson Corp0.64%$4.09M
23PepsiCo Inc0.63%$4.05M
24Verizon Communications Inc0.62%$3.96M
25Wells Fargo & Co0.61%$3.93M

Top 25 of 617 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Vanguard U.S. Multifactor ETF holdings by asset type
Asset type% of fund
Stocks99.76%
Cash and short-term investments0.23%
Derivatives0.01%
Vanguard U.S. Multifactor ETF holdings by country, largest 1
Country% of fund
United States99.98%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Vanguard U.S. Multifactor ETF's total return was +6.00%, as reported to the SEC.

Vanguard U.S. Multifactor ETF monthly total returns
MonthTotal return
May 31, 2026+1.83%
Apr 30, 2026+8.54%
Mar 31, 2026−4.10%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Vanguard U.S. Multifactor ETF
Ticker
VFMF
Exchange
BATS
Fund type
ETF
Trust
VANGUARD WELLINGTON FUND
SEC series ID
S000061310
SEC CIK
0000105563
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by VANGUARD WELLINGTON FUND, the trust behind Vanguard U.S. Multifactor ETF, and cover all of its funds.

Frequently asked questions

What is VFMF's price?

Vanguard U.S. Multifactor ETF (VFMF) closed at $214.06 on Oct 9, 2026, up 0.92% from the previous close of $212.10.

What is VFMF's expense ratio?

Vanguard U.S. Multifactor ETF's expense ratio is 0.18%: $18.00 a year on $10,000 invested.

What does VFMF hold?

Vanguard U.S. Multifactor ETF held 617 investments worth $641.90M as of May 31, 2026. Its largest holding was Micron Technology Inc, at 1.25% of the fund. Its five largest holdings were Micron Technology Inc, Newmont Corp, Bristol-Myers Squibb Co, ConocoPhillips, Bank of New York Mellon Corp/The.

How has VFMF performed?

Over the 3 months to May 31, 2026, Vanguard U.S. Multifactor ETF's total return was +6.00%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Nov 30, 2025. Prices are generated sample data for development. Data sources and disclosures